高级检索
当前位置: 首页 > 详情页

Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP) ◇ 自然指数

机构: [1]Peking Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Peoples Hosp, Beijing, Peoples R China [2]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, West Roxbury, MA USA [3]Zhengzhou Univ, Afliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China [4]Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China [5]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin, Peoples R China [6]Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China [7]Tianjin Inst Hlth Sci, Tianjin, Peoples R China [8]Shenzhen Univ, Peoples Hosp Shenzhen 2, Afliated Hosp 1, Dept Hematol, Shenzhen, Peoples R China [9]Shenzhen Second Peoples Hosp, Dept Hematol, Shenzhen, Peoples R China [10]Shenzhen Univ, Shenzhen Peoples Hosp 2, Afliated Hosp 1, Dept Hematol, Shenzhen, Peoples R China [11]Shenzhen Univ, Shenzhen Peoples Hosp 2, Afliated Hosp 1, Shenzhen Bone Marrow Transplantat Publ Serv Platfo, Shenzhen, Peoples R China [12]Sichuan Acad Med Sci Sichuan Prov, Dept Hematol, Chengdu, Sichuan, Peoples R China [13]Shanxi Med Univ, Afliated Hosp 2, Dept Hematol, Taiyuan, Peoples R China [14]Shanxi Med Univ, Hosp 2, Dept Hematol, Taiyuan, Peoples R China [15]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China [16]Southern Med Univ, Shenzhen Hosp, Shenzhen, Peoples R China [17]Xian Int Med Ctr Hosp, Xian, Peoples R China [18]Xian Int Med Ctr, Xian, Peoples R China [19]Weifang Peoples Hosp, Dept Hematol, Weifang, Peoples R China [20]Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China [21]Zhejiang Univ Sch Med, Afliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China [22]Zhejiang Prov Clin Res Ctr Hematol Disorders, Hangzhou, Peoples R China [23]Zhejiang Univ, Zhejiang Prov Key Lab Hematopoiet Malignancy, Hangzhou, Peoples R China [24]Army Med Univ, Xinqiao Hosp, Chongqing, Peoples R China [25]First Peoples Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China [26]Xingan League Peoples Hosp, Xingan, Inner Mongolia, Peoples R China [27]Jiangsu Prov Peoples Hosp, Dept Hematol, Nanjing, Peoples R China [28]Inner Mongolia Med Univ, Afliated Hosp, Hohhot, Peoples R China [29]Guangxi Med Univ, Afliated Hosp 1, Nanning, Peoples R China [30]Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Hematol, Guangzhou, Peoples R China [31]Guangdong Prov Peoples Hosp, Guangzhou, Guangdong, Peoples R China [32]Peking Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Peoples Hosp,Beijing Key Lab Hematopoiet Stem Cell, Beijing, Peoples R China
出处:
ISSN:
语种:
WOS:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 医学
小类 | 1 区 血液学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 血液学
JCR分区:
出版当年[2023]版:
Q1 HEMATOLOGY
最新[2023]版:
Q1 HEMATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Peking Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Peoples Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:90955 今日访问量:0 总访问量:764 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号 ICP备案:滇ICP备15003244号